Cryofocus Medtech (Shanghai) Co (HKSE:06922) EV-to-Revenue : 50.94 (As of Apr. 26, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cryofocus Medtech (Shanghai) Co's enterprise value is HK$2,281.65 Mil. Cryofocus Medtech (Shanghai) Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$44.79 Mil. Therefore, Cryofocus Medtech (Shanghai) Co's EV-to-Revenue for today is 50.94.

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's EV-to-Revenue or its related term are showing as below:

HKSE:06922' s EV-to-Revenue Range Over the Past 10 Years
Min: 64.35 Med: 120.84 Max: 148.31
Current: 50.94

During the past 4 years, the highest EV-to-Revenue of Cryofocus Medtech (Shanghai) Co was 148.31. The lowest was 64.35. And the median was 120.84.

HKSE:06922's EV-to-Revenue is ranked worse than
94.05% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.04 vs HKSE:06922: 50.94

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-26), Cryofocus Medtech (Shanghai) Co's stock price is HK$9.99. Cryofocus Medtech (Shanghai) Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.19. Therefore, Cryofocus Medtech (Shanghai) Co's PS Ratio for today is 53.14.

Cryofocus Medtech (Shanghai) Co EV-to-Revenue Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co EV-to-Revenue Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

132.10

98.51

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial			-	-	132.10	-	-

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's EV-to-Revenue

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's EV-to-Revenue falls into.

Cryofocus Medtech (Shanghai) Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cryofocus Medtech (Shanghai) Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	2281.645	/	44.791
	=	50.94

Cryofocus Medtech (Shanghai) Co's current Enterprise Value is HK$2,281.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cryofocus Medtech (Shanghai) Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$44.79 Mil.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cryofocus Medtech (Shanghai) Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	9.99	/	0.188
	=	53.14

Cryofocus Medtech (Shanghai) Co's share price for today is HK$9.99.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.19.

Cryofocus Medtech (Shanghai) Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines